EPIP1 - Overview: Epithelia Panel # 1, Serum

Establishing a diagnosis of an allergy to cat, cow, dog, or horse Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm...

GRAS2 - Overview: Grass Panel # 2, Serum

Establishing a diagnosis of an allergy to Bahia, Bermuda, Johnson, June/Kentucky blue, rye, and timothy Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...

GRAS3 - Overview: Grass Panel # 3, Serum

Establishing a diagnosis of an allergy to cultivated rye, rye, sweet vernal, timothy, and velvet leaf Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or...

MTBS - Overview: Microsporidia Stain, Varies

Diagnosis of extra-intestinal microsporidiosis involving the lung, skin, and other organs, particularly in immunocompromised hosts Diagnosis of ocular microsporidiosis

CALJM - Overview: CALR Variant Analysis, Myeloproliferative Neoplasm, Reflex, Bone Marrow

Aiding in the distinction between a reactive cytosis and a chronic myeloproliferative disorder Evaluating for variants in CALR in an algorithmic process

CTFNA - Overview: Cytology Fine-Needle Aspiration, Varies

Detection of malignancy Detection of certain inflammatory conditions

TACPK - Overview: Tacrolimus, Peak, Blood

Assessment of postdosing (peak) blood tacrolimus concentrations

BVRNA - Overview: Bacterial Vaginosis, Nucleic Acid Amplification, Vaginal

Aid for diagnosis of bacterial vaginosis This test is not intended for use in medico-legal applications.

ZONI - Overview: Zonisamide, Serum

Monitoring zonisamide therapy; recommended for all patients to ensure appropriate dosing Assessing medication compliance

CMVC8 - Overview: Cytomegalovirus (CMV) CD8 T-Cell Immune Competence, Quantitative Assessment by Flow Cytometry, Blood

Assessing cytomegalovirus (CMV)-specific immune competence in allo-hematopoietic stem cell transplantation patients who are at risk for developing late CMV disease (beyond day 100 after transplant) Assessing CMV-specific immune competence...